Rafferty Asset Management, LLC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$21,000
-76.1%
69,420
+8.7%
0.00%
-100.0%
Q1 2022$88,000
+87.2%
63,877
+63.5%
0.00%
Q4 2021$47,000
-26.6%
39,071
+58.9%
0.00%
Q3 2021$64,00024,5920.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders